Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team

What are you looking for?

  • Conference Roundup
  • Contact Lenses
  • Diagnostics
  • Glaucoma
  • Myopia
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Retina
  • Spotlight Series
Navigating Presbyopia Conversations with Patients in Practice
Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team
Home > Low-dose atropine may reduce visual discomfort in adolescents with myopia
  • Myopia

Low-dose atropine may reduce visual discomfort in adolescents with myopia

Optometry 360

Key Takeaways

  1. Low-dose atropine (0.01%) was not associated with increased visual discomfort, with inverse probability weighting analysis showing significantly lower discomfort scores among atropine users.
  2. The reduction in visual discomfort was greater at higher correlated color temperatures, while no significant differences were found in glare threshold, pattern-glare scores, pupil diameters, or reading speed.

Low-dose atropine (0.01%) was not associated with increased visual discomfort in adolescents with myopia and may provide a modest protective effect under certain lighting conditions, according to a study.

The study included 120 adolescents aged 12 to 18 years with myopia ranging from −3.00 to −6.00 diopters.

Researchers compared 69 patients using low-dose atropine with 51 non-atropine controls. Visual discomfort under standardized lighting conditions using the Visual Discomfort Scale (VDS-10) was assessed.

Unadjusted results showed lower mean visual discomfort scores among atropine users compared with controls (3.56 vs 4.67). However, adjusted ordinary least squares analysis found no significant association between atropine use and visual discomfort (P = 0.598). In contrast, inverse probability of treatment weighting analysis showed a significant reduction in discomfort among atropine users (P < 0.001).

An interaction analysis found that the reduction in discomfort was greater at higher correlated color temperatures among atropine users. No significant group differences were observed in glare threshold, pattern-glare scores, pupil diameters, or reading speed.

Reference

Charan LS, Mahaur V, Tripathi H. Low-dose atropine (0.01%) and visual discomfort: A clinic-based cohort linking pupil metrics, lighting context, and symptomatology in myopia control. Vision Res. 2026;251:108927. doi: 10.1016/j.visres.2026.108927. Epub ahead of print. PMID: 43038592.

Share

Related Content

  • Myopia

Demographic and clinical factors linked to low-dose atropine treatment in children

  • Myopia

Theialife plans Phase 3 trials of oral ND10 for progressive pediatric myopia

  • Myopia

High-dose atropine plus dual-focus lenses show minimal myopia progression

  • Myopia

Myopia Action Month: empowering practices to take the next step in myopia management

  • Myopia

New tool measures parents’ knowledge and practices related to myopia prevention

  • Myopia

Low-dose atropine linked to sustained myopia control and minimal rebound

Share

Advisory Board

Kaleb Abbott, OD, MS, FAAO

Clark Chang, OD

Jessica Haynes, OD, FAAO, FORS, Dipl ABO

Monica Kalia, OD

Cecelia Koetting, OD, FAAO, DipABO

Roya Attar, OD, MBA, DHA, FAAO

Hardeep Kataria, OD, FAAO

Marc R. Bloomenstein, OD, FAAO

Elise Kramer, OD

See All
Optometry 360

Optometry 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

© 2026 Optometry 360 is a trademark of International Healthcare Media, LLC. All rights Reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophthalmology360 Icon